1. Home
  2. CUPR

as 07-11-2025 3:34pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

NYSE

Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.

Founded: 2019 Country:
Singapore
Singapore
Employees: N/A City: N/A
Market Cap: 43.2M IPO Year: 2025
Target Price: N/A AVG Volume (30 days): 300.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.06 EPS Growth: N/A
52 Week Low/High: $3.51 - $7.46 Next Earning Date: 01-01-0001
Revenue: $35,406 Revenue Growth: -52.05%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: